HeartCore Enterprises, Inc. — Form 8-K Summary
Business Context and Reporting Period
HeartCore Enterprises, Inc. filed this Current Report on October 23, 2023, reporting entry into an at-the-market offering agreement with H.C. Wainwright & Co., LLC. The company’s common stock trades on the Nasdaq Capital Market under the symbol HTCR.
Material Financing Terms and Key Metrics
- The company may issue and sell up to $1,988,229 of common stock through or to H.C. Wainwright under the effective Form S-3 registration statement.
- Shares may be sold in at-the-market transactions, and in privately negotiated transactions with the company’s prior written approval.
- The company controls the timing, amount and minimum price of sales and has no obligation to sell shares.
- H.C. Wainwright will receive a cash commission of 4.0% of gross sales proceeds when acting as sales agent. Different terms may apply when it acts as principal.
- The company must reimburse reasonable legal fees and expenses of up to $75,000, plus specified additional diligence-related amounts.
- Settlement generally occurs on the second trading day after a sale; the filing notes that a shorter settlement cycle may apply beginning May 28, 2024.
- The filing does not provide revenue, profit, cash flow, margin, debt, cash balance or liquidity figures for the reporting period.
Material Changes, Outlook and Risks
The material change disclosed is the establishment of a new equity financing facility. If shares are sold, the company would receive additional capital, but existing shareholders could experience dilution. The filing does not state how much stock, if any, had been sold as of the filing date.
The offering terminates upon the earlier of aggregate sales of $1,988,229 or termination of the agreement. The company may terminate on 10 business days’ written notice, while H.C. Wainwright may terminate provisions relating to solicitation of offers at any time. Neither party is required to complete sales.
The agreement contains customary representations, warranties and covenants. The company agreed to indemnify and provide contribution to the manager for certain liabilities, including liabilities under the Securities Act. Proceeds are not subject to an escrow, trust or similar arrangement.
Important Facts for Investors to Verify
- Whether any shares were actually sold under the ATM facility and the remaining authorized sales capacity.
- The number of shares issued, offering prices and net proceeds after commissions and expenses.
- The potential dilution relative to the company’s outstanding shares and public float.
- How the proceeds are expected to be used and whether additional financing may be required.
- The complete agreement, prospectus supplement, registration statement and legal opinion filed as Exhibits 10.1, 5.1 and 23.1.